-
OCT Companies in the News
-
Location, Location—Innovation: Companies in key U.S. regions continue to dominate medtech innovation, but the names on their patents often come with overseas addresses.
Explore Article Medical Device Link (Nov 21 2008)
...en one thinks of important medical device innovators, large multinational companies such as Abbott, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic, and Siemens all come to mind. But identifying the regional sources of the innovations that drive these companie... (Read Full Article)
Comment on Article Mentions: GlucoLight Boston Scientific Cordis
-
Best Practices in Medical Technologies & Life Sciences Recognized with Frost & Sullivan Awards
Explore Article businesswire.com (Mar 17 2008)
...Bioptigen Inc. -- 2007 North American Optical Coherence Tomography Excellence in Research Award Boston Scientific -- 2008 North American Neurostimulation Market Share Advancement Award -AND- 2008 United States Cor...... Award Raymedica, LLC -- 2008 United States Prosthetic Disc Nuclei Hot Investment Opportunity Award Siemens Medical Systems -- 2008 North American C-arm Technology Innovation Award Signalife -- 2008 North Am... (Read Full Article)
Comment on Article Mentions: Bioptigen Boston Scientific Siemens
-
Innovation: patent applications review
Explore Article Medical Physics (Jan 18 2008)
...e * IBM, Mayo target imaging innovation * Elekta goes shopping * More news articles Related Links * Boston Scientific * University of California * Carl Zeiss Meditec * General Electric Company * Siemens Medical Solutions REGISTER NOW Become a member of medicalphysicsweb to access our PREMIUM content a... (Read Full Article)
Comment on Article Mentions: Carl Zeiss Meditec Boston Scientific Siemens






Recent Comments
Eric Swanson » The Evolution of Spectral Domain OCT
For more information see http://octnews.hivefire.com/entity/profile/oct-information-on-ophthalmology-website/
bernie » Morphology and Epidermal Thickness of Normal Skin Imaged by Optical Coherence Tomography.
Interesting
See all recent comments